Back
Pfizer Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
21
PFE
Pfizer
Last Price:
28.58
Seasonality Move:
5.42%
Sell
26
SRPT
Sarepta Therapeutics
Last Price:
120.15
Seasonality Move:
-0.82%
Sell
21
Pfizer (PFE)
is a Sell
Is Pfizer a Buy, Sell or Hold?
- The current Pfizer [PFE] share price is $28.58. The Score for PFE is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- PFE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $120.40. The Score for SRPT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $120.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
PFE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 42.59 | Sell |
| Chaikin Money Flow: | 26578513 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.6 - 29.62) | Sell |
| Bollinger Bands (100): | (28.04 - 29.7) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.41 | Sell |
| Relative Strength Index (14 RSI): | 32.45 | Sell |
| Chaikin Money Flow: | 79309 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (122.31 - 130.81) | Sell |
| Bollinger Bands (100): | (122.97 - 147.31) | Sell |
PFE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.77 | Sell |
| 20-day SMA: | 29.25 | Sell |
| 50-day SMA: | 29.2 | Sell |
| 200-day SMA: | 28.18 | Buy |
| 8-day EMA: | 28.77 | Sell |
| 20-day EMA: | 28.99 | Sell |
| 50-day EMA: | 29.01 | Sell |
| 200-day EMA: | 29.44 | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 122.86 | Sell |
| 20-day SMA: | 124.78 | Sell |
| 50-day SMA: | 132.71 | Sell |
| 200-day SMA: | 128.28 | Sell |
| 8-day EMA: | 122.39 | Sell |
| 20-day EMA: | 125.48 | Sell |
| 50-day EMA: | 130.61 | Sell |
| 200-day EMA: | 128.3 | Sell |
Pfizer Earnings Growth & PFE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.12 per share, and an increase next year of $0.21 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.81 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.
Pfizer Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||